Ovintiv Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $11.1 Billion | 3/12 | CNQ $63.4B |
EQT $31.2B |
OVV $11.1B |
RRC $9.3B |
SWN $7.8B |
CPG $5.3B |
CRK $5.2B |
ESTE $3.0B |
CPE $2.4B |
VET $1.4B |
SBOW $940.4M |
SD $446.2M |
Gross Margin | 90% | 4/12 | SD 100% |
RRC 95% |
ESTE 91% |
OVV 90% |
EQT 89% |
CRK 84% |
CPE 83% |
VET 53% |
SBOW 38% |
CPG 30% |
CNQ 29% |
SWN 2% |
Profit Margin | 22% | 4/12 | SD 85% |
CPE 28% |
ESTE 26% |
OVV 22% |
CNQ 22% |
VET 10% |
RRC 8% |
EQT -5% |
SBOW -6% |
CRK -22% |
CPG -40% |
SWN -56% |
EBITDA margin | 50% | 5/12 | SBOW 64% |
CPG 61% |
CPE 56% |
VET 54% |
OVV 50% |
CRK 45% |
CNQ 44% |
SD 44% |
EQT 41% |
ESTE 41% |
RRC 26% |
SWN 15% |
Quarterly Revenue | $2.3 Billion | 3/12 | EQT $3.6T |
CNQ $7.8B |
OVV $2.3B |
SWN $1.1B |
CPG $768.6M |
RRC $615.0M |
CPE $601.4M |
ESTE $475.8M |
VET $379.4M |
SBOW $256.7M |
CRK $253.6M |
SD $30.1M |
Quarterly Earnings | $507.0 Million | 2/12 | CNQ $1.7B |
OVV $507.0M |
CPE $169.0M |
ESTE $125.0M |
RRC $50.7M |
VET $38.9M |
SD $25.5M |
SBOW -$15.5M |
CRK -$55.1M |
CPG -$309.5M |
SWN -$608.0M |
EQT -$185.2B |
Quarterly Free Cash Flow | -$538.0 Million | 11/12 | CNQ $1.2B |
CRK $686.4M |
RRC $568.1M |
SBOW $121.3M |
CPE $80.3M |
SD $26.5M |
EQT $23.5M |
VET $8.7M |
CPG -$5.0M |
SWN -$168.0M |
OVV -$538.0M |
ESTE -$728.8M |
Trailing 4 Quarters Revenue | $9.9 Billion | 3/12 | EQT $3.6T |
CNQ $28.0B |
OVV $9.9B |
SWN $3.3B |
CPG $2.7B |
RRC $2.4B |
CPE $1.8B |
ESTE $1.8B |
VET $1.5B |
CRK $1.2B |
SBOW $769.1M |
SD $91.4M |
Trailing 4 Quarters Earnings | $2.0 Billion | 2/12 | EQT $3.6T |
CNQ $7.8B |
OVV $2.3B |
SWN $1.1B |
CPG $768.6M |
RRC $615.0M |
CPE $601.4M |
ESTE $475.8M |
VET $379.4M |
SBOW $256.7M |
CRK $253.6M |
SD $30.1M |
Quarterly Earnings Growth | 25% | 2/12 | SD 36% |
OVV 25% |
RRC 2% |
CNQ -3% |
VET -10% |
CPE -38% |
ESTE -41% |
SBOW -116% |
CPG -290% |
SWN -363% |
CRK -474% |
EQT -228077% |
Annual Earnings Growth | 44% | 3/12 | RRC 244% |
CPG 95% |
OVV 44% |
CRK 27% |
CNQ 13% |
ESTE -30% |
SD -34% |
SBOW -69% |
CPE -79% |
SWN -146% |
VET -289% |
EQT -155543% |
Quarterly Revenue Growth | -12% | 8/12 | EQT 361574% |
SBOW 83% |
SWN 36% |
CPG 26% |
RRC 8% |
VET -4% |
ESTE -10% |
OVV -12% |
CNQ -12% |
CPE -15% |
SD -21% |
CRK -33% |
Annual Revenue Growth | -3% | 7/12 | EQT 102103% |
RRC 13% |
SBOW 4% |
CPG 2% |
CRK 0% |
VET -2% |
OVV -3% |
CNQ -3% |
ESTE -10% |
SD -34% |
CPE -43% |
SWN -54% |
Cash On Hand | $9.0 Million | 10/12 | CNQ $542.1M |
RRC $277.5M |
VET $143.6M |
SD $92.7M |
EQT $89.0M |
ESTE $16.6M |
CPG $16.4M |
SWN $15.0M |
CRK $13.8M |
OVV $9.0M |
CPE $3.3M |
SBOW $1.4M |
Short Term Debt | $1.9 Billion | 1/12 | OVV $1.9B |
CNQ $1.2B |
RRC $708.7M |
SWN $431.0M |
EQT $400.2M |
CPG $319.8M |
SBOW $45.3M |
CRK $35.4M |
ESTE $2.3M |
CPE -$0 |
SD -$0 |
VET -$0 |
Long Term Debt | $4.9 Billion | 3/12 | EQT $13.4B |
CNQ $6.3B |
OVV $4.9B |
SWN $3.8B |
CRK $2.9B |
CPG $2.4B |
CPE $1.9B |
ESTE $1.7B |
RRC $1.1B |
SBOW $1.0B |
VET $770.8M |
SD $0 |
PE | 5.45 | 6/12 | RRC 19.29 |
CNQ 11.10 |
SD 9.83 |
ESTE 6.55 |
CPE 5.93 |
OVV 5.45 |
SBOW 5.01 |
SWN -1.00 |
EQT -1.00 |
CPG -1.00 |
CRK -1.00 |
VET -1.00 |
PS | 1.13 | 11/12 | SD 4.88 |
CRK 4.19 |
RRC 3.91 |
CNQ 3.01 |
CPG 2.58 |
SWN 2.39 |
ESTE 1.70 |
CPE 1.30 |
VET 1.25 |
SBOW 1.22 |
OVV 1.13 |
EQT 0.01 |
PB | 1.04 | 8/12 | RRC 2.40 |
CNQ 2.11 |
SWN 2.08 |
CRK 1.86 |
EQT 1.53 |
ESTE 1.15 |
CPG 1.11 |
OVV 1.04 |
SBOW 0.80 |
SD 0.79 |
VET 0.66 |
CPE 0.60 |
PC | 1235.67 | 1/12 | OVV 1235.67 |
CPE 715.29 |
SBOW 650.32 |
SWN 522.81 |
CRK 377.74 |
EQT 351.18 |
CPG 323.86 |
ESTE 179.53 |
CNQ 116.88 |
RRC 33.47 |
VET 9.99 |
SD 4.81 |
Liabilities to Equity | 5.66 | 1/12 | OVV 5.66 |
CRK 1.72 |
SWN 1.62 |
ESTE 1.41 |
SBOW 1.29 |
VET 1.11 |
EQT 0.96 |
CPG 0.89 |
CNQ 0.88 |
RRC 0.87 |
CPE 0.68 |
SD 0.00 |
ROA | 0.03 | 7/12 | ESTE 9% | CNQ 8% | SD 8% | RRC 7% | SBOW 7% | CPE 6% | OVV 3% | CPG 0% | CRK -1% | VET -10% | SWN -28% | EQT -462% |
ROE | 0.19 | 2/12 | ESTE 25% |
OVV 19% |
SBOW 16% |
CNQ 14% |
RRC 12% |
CPE 10% |
CPG -1% |
CRK -4% |
VET -22% |
SWN -73% |
SD -100% |
EQT -908% |
Current Ratio | 1.18 | 11/12 | CPE 2.47 |
RRC 2.15 |
CNQ 2.13 |
CPG 2.13 |
EQT 2.05 |
ESTE 2.01 |
VET 1.90 |
SBOW 1.77 |
CRK 1.71 |
SWN 1.62 |
OVV 1.18 |
SD -1.00 |
Quick Ratio | 0.00 | 5/12 | RRC 19.29 |
CNQ 11.10 |
SD 9.83 |
ESTE 6.55 |
CPE 5.93 |
OVV 5.45 |
SBOW 5.01 |
SWN -1.00 |
EQT -1.00 |
CPG -1.00 |
CRK -1.00 |
VET -1.00 |
Long Term Debt to Equity | 0.46 | 8/12 | CRK} 1.28 |
SWN} 1.01 |
ESTE} 0.95 |
SBOW} 0.88 |
EQT} 0.66 |
CPG} 0.50 |
CPE} 0.48 |
OVV} 0.46 |
VET} 0.36 |
RRC} 0.29 |
CNQ} 0.21 |
SD} -1.00 |
Debt to Equity | 0.63 | 6/12 | CRK 1.28 |
SWN 1.14 |
ESTE 0.95 |
SBOW 0.93 |
EQT 0.68 |
OVV 0.63 |
CPG 0.58 |
CPE 0.48 |
RRC 0.47 |
VET 0.36 |
CNQ 0.25 |
SD -1.00 |
Burn Rate | 0.05 | 4/12 | VET 89.37 |
RRC 1.62 |
CRK 0.08 |
OVV 0.05 |
CPG 0.04 |
SWN 0.02 |
SBOW 0.02 |
EQT 0.00 |
CPE -0.04 |
ESTE -0.30 |
CNQ -0.75 |
SD -3.64 |
Cash to Cap | 0.00 | 6/12 | SD 0.21 |
VET 0.10 |
RRC 0.03 |
CNQ 0.01 |
ESTE 0.01 |
OVV 0.00 |
SWN 0.00 |
CPE 0.00 |
EQT 0.00 |
CPG 0.00 |
CRK 0.00 |
SBOW 0.00 |
CCR | -1.06 | 9/12 | RRC 11.22 |
SD 1.04 |
CNQ 0.73 |
CPE 0.48 |
SWN 0.28 |
VET 0.23 |
CPG 0.02 |
EQT 0.00 |
OVV -1.06 |
ESTE -5.83 |
SBOW -7.81 |
CRK -12.45 |
EV to EBITDA | 15.45 | 6/12 | SWN} 76.80 |
CRK} 71.75 |
RRC} 68.86 |
SD} 26.77 |
ESTE} 24.07 |
OVV} 15.45 |
CPE} 12.68 |
CNQ} 12.49 |
SBOW} 12.42 |
CPG} 12.41 |
VET} 7.06 |
EQT} 0.03 |
EV to Revenue | 1.81 | 10/12 | CRK 6.55 |
RRC 4.56 |
SD 3.87 |
SWN 3.70 |
CPG 2.82 |
ESTE 2.67 |
SBOW 2.65 |
CPE 2.34 |
CNQ 2.03 |
OVV 1.81 |
VET 1.26 |
EQT 0.01 |